| JYHZ2400073 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | License Renew | 2024-03-26 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHZ2300034 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | License Renew | 2023-01-18 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | | | view |
| JYHZ2300033 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | License Renew | 2023-01-18 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | | | view |
| JYHZ2100573 | 糠酸氟替卡松鼻用喷雾剂 | fluticasone furoate | Spray | Chemical Drugs | License Renew | 2021-07-08 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | | | view |
| JYHB2400459 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-08-20 | | Glaxo Operations UK Ltd;GlaxoSmithKline Intellectual Property Development Ltd | | | view |
| JYHB2400111 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-03-02 | | Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHB2300730 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2023-12-19 | | Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHB2300304 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2023-05-24 | | Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHB2200313 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2022-06-21 | | Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHB2101626 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-12-30 | | Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | | | view |
| JYHB2101625 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-12-30 | | Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | | | view |
| JYHB2100113 | 糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅲ） | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-02-03 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd | In Review | 2021-02-03 | view |
| JYHB2100112 | 糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅱ） | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-02-03 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd | In Review | 2021-02-03 | view |
| JYHB2100015 | 糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅲ） | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-01-08 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | Certificate Issued | 2021-02-01 | view |
| JYHB2100014 | 糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅱ） | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-01-08 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | Certificate Issued | 2021-02-01 | view |
| JYHB2002759 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | In Review | 2021-01-04 | view |
| JYHB2002664 | 糠酸氟替卡松鼻用喷雾剂 | fluticasone furoate | Spray | Chemical Drugs | Supplementary Application | 2020-12-25 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | In Review | 2020-12-23 | view |
| JYHB2001496 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2020-08-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | Filed | 2020-08-31 | view |
| JYHB2001111 | 糠酸氟替卡松鼻用喷雾剂 | fluticasone furoate | Spray | Chemical Drugs | Supplementary Application | 2020-06-28 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | Filed | 2020-06-30 | view |
| JYHB2000258 | 糠酸氟替卡松鼻用喷雾剂 | fluticasone furoate | Spray | Chemical Drugs | Supplementary Application | 2020-03-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | Certificate Issued | 2020-04-22 | view |
